All builds

Bioprinting · Extrusion · 2024 · (MDPI journal; see landing)

Design and Validation of a Piston-Driven Syringe-Extrusion Bioprinter Using an FDM Frame

Direct ink writing (DIW) deposits viscous, shear-responsive inks at low temperature, enabling hydrogels and cell-laden bioinks for biomedical fabrication. Access to DIW remains limited by the cost of dedicated systems and the complexity of custom motion control.

Performance the paper reports

1 of 5
  1. Motion—Motion accuracy: not reported
  2. Volume—Volumetric accuracy: not reported
  3. Viability86.3%Cell viability: reported
  4. Unattended—Unattended operation: not reported
  5. Standard—Standard compliance: not reported
  • Cell viability86.3%
    Biologically, DMs offered an ECM-like microenvironment and shear resistance, sig- nificantly boosting post-printing cell viability (~86.3%) compared to GelMA alone.

How hard this is to adopt

3.3 of 5, higher is easier

Each score is shown against the range the other 59 builds actually occupy, because no criterion uses the full 1–5 scale. These describe how reproducible the build is, not how good the science is.

  • Resolution

    2/1–5

    Smallest feature/positioning evidence about 600 µm.

  • Throughput

    3/2–5

    Moderate scalability via modularity, batching, or partial automation.

  • Parts sourcing

    4/2–4

    Mostly off-the-shelf or kit-based components.

  • Skill needed

    2/2–4

    Multiple advanced technical skills appear required.

  • Facilities needed

    4/2–4

    Uses common benchtop/desktop equipment or generic consumables.

  • Documentation

    3/2–5

    Some open documentation or files are available.

  • Validation effort

    4/2–4

    Validation includes standards, benchmarking, replicates, or multi-condition tests.

  • Cycle time

    4/1–4

    Speed evidence suggests rapid, real-time, or automated operation.

2 further criteria are recorded but not shown
  • Application Level — scored 4 (75% of records share one value), so it cannot separate one build from another.
  • Build Time (scored for only 6 of 60 records), so it cannot separate one build from another.

Both remain in the published dataset.

Have you built this?

Report what it took, including attempts that stalled. A failed build tells the next laboratory what the documentation leaves out.

Report a rebuild

Know what this record is missing?

The index has no cost, licence on the design files, link to the design files or which files exist (CAD, bill of materials, firmware…) for this build. If you are an author or have built it, you know; a GitHub issue pre-filled with this record takes a minute.

Fill the gap
Record metadata
Publication data

Matched by title · retrieved 2026-07-21

Abstract

Direct ink writing (DIW) deposits viscous, shear-responsive inks at low temperature, enabling hydrogels and cell-laden bioinks for biomedical fabrication. Access to DIW remains limited by the cost of dedicated systems and the complexity of custom motion control. Repurposing fused deposition modeling (FDM) printers lowers these barriers by using accurate motion stages, open firmware, and familiar workflows while preserving build volume. In this study, three DIW actuator designs were implemented on an FDM frame. The first used a gear-and-rail transmission that converted stepper rotation to plunger travel. The second used a direct trapezoidal-screw pusher that increased force but reduced build-space clearance. The third relocated actuation to a remote piston-driven module that decoupled force generation from the printhead. The final architecture integrates the remote piston with partitioned control, where the printer executes motion and a programmable logic controller (PLC) manages extrusion. This arrangement reduces carried mass, preserves build space, and enables precise volumetric dosing with fast response. On a standard desktop frame, the system achieved controllable deposition of an agar/alginate ink using off-the-shelf electronics and modest modifications. This approach promotes sustainable and accessible innovation by repurposing existing FDM printers with open-source hardware and modular components. The resulting platform supports biomimetic biofabrication by combining mechanical efficiency, environmental responsibility, and cost-effective design.

Bibliographic details

Published
2025-12-04
Journal/source
Biomimetics
Publisher
MDPI AG
DOI
10.3390/biomimetics10120811
Type
journal-article
Language
en
Volume / issue
10 / 12
Pages
811
ISSN
2313-7673

Access and metrics

Open access
Yes
OA status
gold
License
cc-by
Version
publishedVersion
Cited by
1
References
26
Retracted
No

Authors and affiliations

  1. Linlin ZhouCalifornia State University, Fullerton
  2. Siheng SuCorresponding authorCalifornia State University, Fullerton

Topics and keywords

3D Printing in Biomedical ResearchNanomaterials and Printing TechnologiesAdditive Manufacturing and 3D Printing TechnologiesModular designActuatorFused deposition modelingRepurposingStepperFrame (networking)Motion controlProgrammable logic controllerPlungerInterfacing
Perspective and practical signals

Why it matters

Another replicable syringe-extrusion build pattern; include if authors provide files.

Limitations

No limitation note curated yet.